Javascript must be enabled to continue!
Time Course and Quantification of Pancreatic Islet Revasculariztion following Intraportal Transplantation
View through CrossRef
A large proportion of islets are lost after transplantation partly due to a lack of functional vasculature. Islets revascularize from host tissue but the process takes up to 2 weeks and has been suggested to result in reduced vascular density in engrafted islets. We describe a method for observing and quantifying the revascularization of intraportally transplanted islets that includes number, density, and branching of islet capillaries. Syngeneic islets were transplanted selectively into the two right posterior lobes of the liver of adult Lewis rats. Sections of the livers were dual stained for insulin and Bandeiraea simplicifolia and analyzed for islet morphology, area, and vascular density from day 0 to day 14 posttransplant and compared to native islets. Vascular density was 1431 ± 75.7 vessels/mm2 in native islets and fell to 325.3 ± 30.8 vessels/mm2 (p < 0.001) by day 1 posttransplant and subsequently increased until day 14 when it was significantly higher than in native islets (2612.5 ± 107.8 vessels/mm2, p < 0.001). The percentage of islet area occupied by vascular space was 9.1 ± 0.9% in native islets. After falling to 2.3 ± 0.3% (p < 0.001) 1 day posttransplant this rose to supranormal levels (21.5 ± 0.8%, p < 0.001) by day 14. The index of capillary branching was 0.771 ± 0.017 in native islets and fell to 0.465 ± 0.02 (p = 0.001) by day 3 but returned to native values by day 7 posttransplantation (0.726 ± 0.03). This technique provides a robust method for tracking and quantifying the revascularization of intraportally transplanted islets, which should enable the comparison of different strategies aimed at accelerating islet revascularization.
Title: Time Course and Quantification of Pancreatic Islet Revasculariztion following Intraportal Transplantation
Description:
A large proportion of islets are lost after transplantation partly due to a lack of functional vasculature.
Islets revascularize from host tissue but the process takes up to 2 weeks and has been suggested to result in reduced vascular density in engrafted islets.
We describe a method for observing and quantifying the revascularization of intraportally transplanted islets that includes number, density, and branching of islet capillaries.
Syngeneic islets were transplanted selectively into the two right posterior lobes of the liver of adult Lewis rats.
Sections of the livers were dual stained for insulin and Bandeiraea simplicifolia and analyzed for islet morphology, area, and vascular density from day 0 to day 14 posttransplant and compared to native islets.
Vascular density was 1431 ± 75.
7 vessels/mm2 in native islets and fell to 325.
3 ± 30.
8 vessels/mm2 (p < 0.
001) by day 1 posttransplant and subsequently increased until day 14 when it was significantly higher than in native islets (2612.
5 ± 107.
8 vessels/mm2, p < 0.
001).
The percentage of islet area occupied by vascular space was 9.
1 ± 0.
9% in native islets.
After falling to 2.
3 ± 0.
3% (p < 0.
001) 1 day posttransplant this rose to supranormal levels (21.
5 ± 0.
8%, p < 0.
001) by day 14.
The index of capillary branching was 0.
771 ± 0.
017 in native islets and fell to 0.
465 ± 0.
02 (p = 0.
001) by day 3 but returned to native values by day 7 posttransplantation (0.
726 ± 0.
03).
This technique provides a robust method for tracking and quantifying the revascularization of intraportally transplanted islets, which should enable the comparison of different strategies aimed at accelerating islet revascularization.
Related Results
Optimizing Post-Transplantation Detection of Subcutaneously Transplanted Islets Using Dithizone Staining
Optimizing Post-Transplantation Detection of Subcutaneously Transplanted Islets Using Dithizone Staining
ABSTRACT
Introduction
Pancreatic islet transplantation is a promising therapeutic strategy to restore insulin independence in p...
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Progressive Islet Graft Failure Occurs Significantly Earlier in Autoantibody-Positive Than in Autoantibody-Negative IDDM Recipients of Intrahepatic Islet Allografts
Alloimmunity has been uncovered to be a cause of graft loss representing a major barrier for clinical islet transplantation, and several studies are designed to evaluate new strate...
Pancreatic Islet Transplantation in Extrahepatic Sites: Evaluation of the Venous Sac in Large Mammal Models
Pancreatic Islet Transplantation in Extrahepatic Sites: Evaluation of the Venous Sac in Large Mammal Models
Background: The long-term clinical efficacy of intraportal islet transplantation is hampered by islet loss due to inflammation, oxidative stress, and insufficient vascularization. ...
Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
Improving Pancreatic Islet Transplantation Using Fibrin Hydrogel Containing Microvascular Fragments in Subcutaneous Tissue of Type I Diabetic Rats
Abstract
Objective(s):
Islet transplantation offers a promising treatment for Type 1 diabetes mellitus
...
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Exosomal-microRNAs Improve Islet Cell Survival and Function In Islet
Transplantation
Abstract:
Exosomal-microRNAs (Exo-miRNAs) are key regulators of islet cell function, including insulin
expression, processing, and secretion. Exo-miRNAs have a significant impact o...
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Current Assessment of Clinical Pancreatic Islet Allotransplantation
Clinical islet allotransplantation represents a minimally invasive, efficacious alternative to pancreas transplantation for restoring glycemic control and insulin independence in s...
Spleen, as an Optimal Site for Islet Transplantation
Spleen, as an Optimal Site for Islet Transplantation
Islet transplantation is a cellular replacement therapy to treat severe diabetes mellitus, but its clinical outcome is unsatisfactory at present. One factor in clinical success of ...
Anti-Oxidative Therapy in Islet Cell Transplantation
Anti-Oxidative Therapy in Islet Cell Transplantation
Islet cell transplantation has become a favorable therapeutic approach in the treatment of Type 1 Diabetes due to the lower surgical risks and potential complications compared to c...

